HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rafał Suwiński Selected Research
Rafał Suwiński Research Topics
Disease
14
Neoplasms (Cancer)
11/2023 - 05/2008
12
Melanoma (Melanoma, Malignant)
01/2023 - 10/2018
8
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2012
7
Neoplasm Metastasis (Metastasis)
11/2023 - 01/2008
4
Prostatic Neoplasms (Prostate Cancer)
01/2023 - 09/2014
3
Brain Neoplasms (Brain Tumor)
04/2022 - 10/2020
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2014
2
Anus Neoplasms (Anal Cancer)
01/2023 - 01/2022
2
Rectal Neoplasms (Rectal Cancer)
05/2021 - 06/2017
2
Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2012
2
Oropharyngeal Neoplasms
01/2019 - 05/2008
2
Head and Neck Neoplasms (Head and Neck Cancer)
01/2017 - 05/2008
2
Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2017 - 01/2012
2
Adenocarcinoma
01/2014 - 01/2012
2
Lung Neoplasms (Lung Cancer)
01/2014 - 01/2012
2
Laryngeal Neoplasms (Laryngeal Cancer)
05/2008 - 01/2008
1
Malignant Mesothelioma
04/2022
1
Disease Progression
10/2020
1
Body Weight (Weight, Body)
01/2020
1
Overweight
01/2020
1
Squamous Cell Carcinoma of Head and Neck
01/2019
1
Nasopharyngeal Carcinoma
01/2017
1
Mucositis
05/2008
1
Stomach Neoplasms (Stomach Cancer)
01/2005
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2005
Drug/Important Bio-Agent (IBA)
4
Platinum
IBA
04/2022 - 10/2012
3
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 01/2019
3
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2023 - 10/2018
3
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
04/2022 - 10/2020
2
pembrolizumab
IBA
01/2023 - 06/2022
2
Nivolumab
IBA
01/2023 - 06/2022
2
Biomarkers (Surrogate Marker)
IBA
04/2022 - 01/2019
2
Cell-Free Nucleic Acids
IBA
01/2022 - 01/2019
2
Fluorouracil (Carac)
FDA Link
Generic
05/2021 - 06/2017
2
Proteins (Proteins, Gene)
FDA Link
10/2020 - 11/2015
2
Serum Amyloid A Protein (Serum Amyloid A)
IBA
01/2014 - 01/2012
2
Proteome
IBA
01/2014 - 01/2012
1
Osteopontin
IBA
11/2023
1
Indicators and Reagents (Reagents)
IBA
01/2023
1
Vemurafenib
IBA
01/2023
1
Hemoglobins (Hemoglobin)
IBA
10/2022
1
Asbestos
IBA
04/2022
1
Pemetrexed (MTA)
FDA Link
04/2022
1
Antibodies
IBA
01/2021
1
Paraffin
IBA
01/2021
1
Formaldehyde (Formol)
FDA Link
01/2021
1
Mitogens
IBA
10/2020
1
Ipilimumab
IBA
09/2020
1
lactate dehydrogenase 2
IBA
09/2020
1
Bevacizumab (Avastin)
FDA Link
01/2020
1
Immune Checkpoint Inhibitors
IBA
10/2019
1
Viral DNA
IBA
01/2019
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2015
1
Androgens
IBA
03/2015
1
Haptoglobins
IBA
01/2014
1
Acute-Phase Proteins (Acute-Phase Protein)
IBA
01/2014
1
Blood Proteins (Serum Proteins)
IBA
01/2014
1
Peptides (Polypeptides)
IBA
01/2012
1
carboxyaminoimidazole ribotide (CAIR)
IBA
05/2008
Therapy/Procedure
17
Therapeutics
11/2023 - 01/2012
15
Radiotherapy
11/2023 - 01/2005
9
Drug Therapy (Chemotherapy)
01/2023 - 01/2005
8
Immunotherapy
01/2023 - 10/2019
6
Chemoradiotherapy
11/2023 - 02/2015
2
Brachytherapy
01/2023 - 03/2015
1
Castration
10/2022